| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/03/2000 | CA2360997A1 Non-invasive method for detecting target rna |
| 08/03/2000 | CA2360690A1 Plasminogen kringle 4 region fragments and methods of use |
| 08/03/2000 | CA2360600A1 A method of controlling fungal pathogens, and agents useful for same |
| 08/03/2000 | CA2360374A1 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 08/03/2000 | CA2360085A1 Genes identified as required for proliferation in escherichia coli |
| 08/03/2000 | CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 08/03/2000 | CA2359317A1 Method of treating restenosis by antisense targeting of c-myc |
| 08/03/2000 | CA2357709A1 Internal ribosome entry site (ires), vector containing same and uses thereof |
| 08/03/2000 | CA2326741A1 The use of gastrin in the treatment of diabetes |
| 08/03/2000 | CA2296936A1 Novel core 2 beta-1,6-n-acetylglycosaminyltransferase |
| 08/02/2000 | EP1024198A2 Pseudo-adenoviral vectors for the gene therapy of haemophiliae |
| 08/02/2000 | EP1024197A2 Mesothelial cell gene therapy |
| 08/02/2000 | EP1023605A1 Methods and compositions for detecting hepatitis e virus |
| 08/02/2000 | EP1023453A2 Tgc method for inducting targeted somatic transgenesis |
| 08/02/2000 | EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 08/02/2000 | EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 08/02/2000 | EP1023319A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 08/02/2000 | EP1023313A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies |
| 08/02/2000 | EP1023085A1 Human embryonic germ cell line and methods of use |
| 08/02/2000 | EP1023048A1 Methods for encapsulating nucleic acids in lipid bilayers |
| 08/02/2000 | EP1023005A1 Method for coating stents with dna and expression of recombinant genes from dna coated stent in vivo |
| 08/02/2000 | CN1261893A 3'-monophosphorylating oligonucleotides |
| 08/02/2000 | CN1261812A Device for nucleic acid carrier optumum electric transferring in vivo of tissue |
| 08/02/2000 | CN1261808A Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 08/02/2000 | CN1261807A Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 08/02/2000 | CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 08/01/2000 | US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents |
| 08/01/2000 | US6096869 Treatment of papillomavirus-associated lesions |
| 08/01/2000 | US6096868 ECR 673: A 7-transmembrane G-protein coupled receptor |
| 08/01/2000 | US6096722 Non-steroidal treatment/prophylaxis |
| 08/01/2000 | US6096721 Administering dna to a patient sublingually without gene transfer or expression to reduce viscosity of respiratory system mucous |
| 08/01/2000 | US6096720 Liposomal oligonucleotide compositions |
| 08/01/2000 | US6096718 Tissue specific adenovirus vectors for breast cancer treatment |
| 08/01/2000 | US6096542 Cancer control |
| 08/01/2000 | US6096538 Retroviral vectors |
| 08/01/2000 | US6096534 Nucleic acid of long terminal repeat from virus, of gag and pol regions of virus, and from viral envelope region; vectors which replicate efficiently in avian cells and replication-defective in mammalian cells; gene therapy and vaccines |
| 08/01/2000 | US6096522 Antibody and method for detecting the human homolog of MAD2 |
| 08/01/2000 | US6096521 Adhesin from Helicobacter pylori |
| 08/01/2000 | US6096520 Brain glycogen phosphorylase cancer antigen |
| 08/01/2000 | US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides |
| 08/01/2000 | US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096335 Stable particulate complexes having a lamellar, rolled, and condensed structure |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | US6096303 Method to enhance treatment of cystic tumors |
| 08/01/2000 | CA2199832C Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/29/2000 | CA2291962A1 Glucose regulated gene |
| 07/29/2000 | CA2258973A1 Glucose regulated gene |
| 07/27/2000 | WO2000043548A1 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
| 07/27/2000 | WO2000043530A2 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043516A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | WO2000043515A2 Methods of monitoring hiv drug resistance |
| 07/27/2000 | WO2000043514A2 Human acid sensing ion channel and uses thereof |
| 07/27/2000 | WO2000043512A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043505A2 Protease with two aspartate radicals in the catalytically active structure |
| 07/27/2000 | WO2000043501A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert) |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043044A1 Compositions and methods for controlled delivery of virus vectors |
| 07/27/2000 | WO2000043043A1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | WO2000042993A2 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
| 07/27/2000 | WO2000042972A2 Compositions and methods for intraductal gene therapy |
| 07/27/2000 | WO2000042856A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |
| 07/27/2000 | WO2000023592A3 Minimal promoters and uses thereof |
| 07/27/2000 | WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 07/27/2000 | WO2000021553A3 Method of regulating smn gene expression |
| 07/27/2000 | WO2000017375A3 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 07/27/2000 | WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface |
| 07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
| 07/27/2000 | DE19902550A1 A novel aspartate protease, coding sequence, inhibitors and antibodies, useful for treatment and diagnosis of Alzheimer's disease |
| 07/27/2000 | DE10003356A1 Novel ribozymes targeted against the catalytic subunit of the human telomerase enzyme reverse transcriptase are useful for treating tumors |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360730A1 Human liver progenitors |
| 07/27/2000 | CA2360585A1 Protease |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2358930A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | CA2358899A1 Polypeptide |
| 07/27/2000 | CA2358873A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | CA2358497A1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery |
| 07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/26/2000 | EP1022340A1 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1022335A1 High-throughput screening of gene function using libraries for functional genomics applications |
| 07/26/2000 | EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
| 07/26/2000 | EP1021550A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021548A1 Method for introducing and expressing rna in animal cells |
| 07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |